consenso brasileiro Nódulos de Tireóide e Câncer Diferenciado de Tireóide: Consenso Brasileiro
暂无分享,去创建一个
Pedro W. R Osário | L. Maciel | M. Vaisman | A. Maia | Universitário Clementino | F. Filho | L. S. Ward
[1] T. Sebo,et al. Papillary thyroid microcarcinoma: a study of 900 cases observed in a 60-year period. , 2008, Surgery.
[2] Á. Barroso,et al. Positive predictive value of detectable stimulated tg during the first year after therapy of thyroid cancer and the value of comparison with Tg-ablation and Tg measured after 24 months. , 2006, Thyroid : official journal of the American Thyroid Association.
[3] J. Franklyn,et al. Serum thyrotropin concentration as a novel predictor of malignancy in thyroid nodules investigated by fine-needle aspiration. , 2006, The Journal of clinical endocrinology and metabolism.
[4] L. Scapozza,et al. Inhibition of RET tyrosine kinase by SU5416. , 2006, Journal of molecular endocrinology.
[5] Jung Hun Song,et al. An orally administered multitarget tyrosine kinase inhibitor, SU11248, is a novel potent inhibitor of thyroid oncogenic RET/papillary thyroid cancer kinases. , 2006, The Journal of clinical endocrinology and metabolism.
[6] S. Larson,et al. Empiric radioactive iodine dosing regimens frequently exceed maximum tolerated activity levels in elderly patients with thyroid cancer. , 2006, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[7] Saulo Purisch,et al. Seguimento de pacientes de alto risco com carcinoma diferenciado de tireóide sem doença persistente após a terapia inicial , 2006 .
[8] L. Bartalena,et al. Surgery of lymph nodes in papillary thyroid cancer , 2006, Expert review of anticancer therapy.
[9] A. Elias,et al. Enhanced Radioiodine Uptake in a Patient With Poorly Differentiated Papillary Thyroid Cancer After Treatment With Rosiglitazone , 2006, Clinical nuclear medicine.
[10] R. Hicks,et al. Management of paediatric thyroid carcinoma: recent experience with recombinant human thyroid stimulating hormone in preparation for radioiodine therapy , 2006, Internal medicine journal.
[11] V. Guimarães,et al. Testicular function after radioiodine therapy in patients with thyroid cancer. , 2006, Thyroid : official journal of the American Thyroid Association.
[12] G. Mariani,et al. Recombinant human thyroid-stimulating hormone is effective for radioiodine ablation of post-surgical thyroid remnants , 2006, Nuclear medicine communications.
[13] J. Kievit,et al. Lithium as adjuvant to radioiodine therapy in differentiated thyroid carcinoma: clinical and in vitro studies , 2006, Clinical endocrinology.
[14] G. Palù,et al. Clinical trials of gene therapy, virotherapy, and immunotherapy for malignant gliomas , 2006, Cancer Gene Therapy.
[15] E. Chin,et al. Thyroid Surgery: Changing Patterns of Practice , 2006, The Laryngoscope.
[16] W. Wiersinga,et al. European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium. , 2006, European journal of endocrinology.
[17] R. Kloos,et al. Phase II study of celecoxib in metastatic differentiated thyroid carcinoma. , 2006, The Journal of clinical endocrinology and metabolism.
[18] Rosalinda Camargo,et al. Câncer diferenciado da tiróide de baixo risco: revisão do estado atual da literatura e proposta de conduta , 2006 .
[19] E. Mazzaferri. Managing small thyroid cancers. , 2006, JAMA.
[20] P. Ladenson,et al. Well-differentiated epithelial thyroid cancer management in the Asia Pacific region: a report and clinical practice guideline. , 2006, Thyroid : official journal of the American Thyroid Association.
[21] A. Pontecorvi,et al. Value of routine measurement of serum calcitonin concentrations in patients with nodular thyroid disease: A multicenter study , 2006, Journal of endocrinological investigation.
[22] S. Mariotti,et al. The diagnostic value for differentiated thyroid carcinoma metastases of thyroglobulin (Tg) measurement in washout fluid from fine-needle aspiration biopsy of neck lymph nodes is maintained in the presence of circulating anti-Tg antibodies. , 2006, The Journal of clinical endocrinology and metabolism.
[23] J. Fagin,et al. Inhibitors of Raf Kinase Activity Block Growth of Thyroid Cancer Cells with RET/PTC or BRAF Mutations In vitro and In vivo , 2006, Clinical Cancer Research.
[24] R. Kloos,et al. Management guidelines for patients with thyroid nodules and differentiated thyroid cancer. , 2006, Thyroid : official journal of the American Thyroid Association.
[25] R. Wahl,et al. Radioiodine ablation of thyroid remnants after preparation with recombinant human thyrotropin in differentiated thyroid carcinoma: results of an international, randomized, controlled study. , 2006, The Journal of clinical endocrinology and metabolism.
[26] M. Santoro,et al. BRAF Is a Therapeutic Target in Aggressive Thyroid Carcinoma , 2006, Clinical Cancer Research.
[27] P. Hall,et al. Clinically significant prognostic factors for differentiated thyroid carcinoma , 2006, Cancer.
[28] V. Guimarães,et al. Radioiodine therapy and age at menopause in patients with thyroid cancer , 2006, Clinical endocrinology.
[29] V. Guimarães,et al. Managing thyroid cancer without thyroxine withdrawal. , 2006, Arquivos brasileiros de endocrinologia e metabologia.
[30] J. Mccaffrey. Aerodigestive Tract Invasion by Well‐Differentiated Thyroid Carcinoma: Diagnosis, Management, Prognosis, and Biology , 2006, The Laryngoscope.
[31] A. Chrisoulidou,et al. Cerebellar metastasis as first metastasis from papillary thyroid carcinoma. , 2005, Endocrine journal.
[32] Q. Duh,et al. Valproic acid inhibits growth, induces apoptosis, and modulates apoptosis-regulatory and differentiation gene expression in human thyroid cancer cells. , 2005, Surgery.
[33] M. Castellano,et al. Is the anteroposterior and transverse diameter ratio of nonpalpable thyroid nodules a sonographic criteria for recommending fine‐needle aspiration cytology? , 2005, Clinical endocrinology.
[34] C. Ahn,et al. Clinical features of bone metastases resulting from thyroid cancer: a review of 28 patients over a 20-year period. , 2005, Endocrine journal.
[35] Á. Barroso,et al. Ultrasonographic Differentiation Between Metastatic and Benign Lymph Nodes in Patients With Papillary Thyroid Carcinoma , 2005, Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine.
[36] C. Spencer,et al. Clinical impact of thyroglobulin (Tg) and Tg autoantibody method differences on the management of patients with differentiated thyroid carcinomas. , 2005, The Journal of clinical endocrinology and metabolism.
[37] E. Baudin,et al. Prognostic factors for persistent or recurrent disease of papillary thyroid carcinoma with neck lymph node metastases and/or tumor extension beyond the thyroid capsule at initial diagnosis. , 2005, The Journal of clinical endocrinology and metabolism.
[38] J. L. Gross,et al. Carcinoma diferenciado de tireide: avaliao inicial e acompanhamento , 2005 .
[39] C. Coeli,et al. [Incidence and mortality from thyroid cancer in Brazil]. , 2005, Arquivos brasileiros de endocrinologia e metabologia.
[40] E. Mazzaferri. Empirically treating high serum thyroglobulin levels. , 2005, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[41] V. Guimarães,et al. Ovarian function after radioiodine therapy in patients with thyroid cancer. , 2005, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.
[42] H. Fideleff,et al. Repeated fine-needle aspiration of the thyroid in benign nodular thyroid disease: critical evaluation of long-term follow-up. , 2005, Thyroid : official journal of the American Thyroid Association.
[43] G. Kovacs,et al. Epidemiology of thyroid microcarcinoma found in autopsy series conducted in areas of different iodine intake. , 2005, Thyroid : official journal of the American Thyroid Association.
[44] M. Luster,et al. rhTSH-aided radioiodine ablation and treatment of differentiated thyroid carcinoma: a comprehensive review. , 2005, Endocrine-related cancer.
[45] P. Cohan,et al. Successful use of recombinant human thyrotropin in the therapy of pediatric well-differentiated thyroid cancer , 2005, Journal of endocrinological investigation.
[46] N. Tamaki,et al. Does lemon candy decrease salivary gland damage after radioiodine therapy for thyroid cancer? , 2005, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[47] V. Guimarães,et al. Thyroglobulin before Ablation and Correlation with Posttreatment Scanning , 2005, The Laryngoscope.
[48] David Goldenberg,et al. The Role of Positron Emission Tomography/Computed Tomography in the Management of Recurrent Papillary Thyroid Carcinoma , 2005, The Laryngoscope.
[49] Pedro Wesley Souza Do Rosário,et al. Post I-131 Therapy Scanning in Patients With Thyroid Carcinoma Metastases: An Unnecessary Cost or a Relevant Contribution? , 2004, Clinical nuclear medicine.
[50] Rosalinda Camargo,et al. Avaliação ultra-sonográfica da tireóide e determinação da iodúria em escolares de diferentes regiões do Estado de São Paulo , 2004 .
[51] A. Atri,et al. Thyroid nodule shape and prediction of malignancy. , 2004, Thyroid : official journal of the American Thyroid Association.
[52] H. Baskin. Detection of recurrent papillary thyroid carcinoma by thyroglobulin assessment in the needle washout after fine-needle aspiration of suspicious lymph nodes. , 2004, Thyroid : official journal of the American Thyroid Association.
[53] H. Yamashita,et al. Modified Radical Neck Dissection for Differentiated Thyroid Cancer: Operative Technique , 2004, World Journal of Surgery.
[54] G. Thompson,et al. Current Strategies for Surgical Management and Adjuvant Treatment of Childhood Papillary Thyroid Carcinoma , 2004, World Journal of Surgery.
[55] Á. Barroso,et al. Efficacy of low and high 131I doses for thyroid remnant ablation in patients with differentiated thyroid carcinoma based on post-operative cervical uptake , 2004, Nuclear medicine communications.
[56] M. Santoro,et al. Identification of RET Kinase Inhibitors as Potential New Treatment for Sporadic and Inherited Thyroid Cancer , 2004, Journal of chemotherapy.
[57] L. Hegedüs,et al. The Thyroid Nodule , 2004 .
[58] J. Montes,et al. Iodine nutrition improves in Latin America. , 2004, Thyroid : official journal of the American Thyroid Association.
[59] T. A. Fagundes,et al. Antithyroglobulin antibodies in patients with differentiated thyroid carcinoma: methods of detection, interference with serum thyroglobulin measurement and clinical significance. , 2004, Arquivos brasileiros de endocrinologia e metabologia.
[60] R. Maciel. Ainda em busca do ensaio ideal para a tiroglobulina sérica no seguimento de pacientes com câncer diferenciado da tiróide , 2004 .
[61] H. Gerstein,et al. A Systematic Review and Metaanalysis of the Effectiveness of Radioactive Iodine Remnant Ablation for Well-Differentiated Thyroid Cancer , 2004 .
[62] J. Hennessey,et al. Two-week low iodine diet is necessary for adequate outpatient preparation for radioiodine rhTSH scanning in patients taking levothyroxine. , 2004, Thyroid : official journal of the American Thyroid Association.
[63] N. Avenia,et al. Locally advanced thyroid cancer: therapeutic options. , 2004, Chirurgia italiana.
[64] L. Kowalski,et al. Postoperative complications of thyroidectomy for differentiated thyroid carcinoma. , 2004, American journal of otolaryngology.
[65] Sebastiano Filetti,et al. Follow-up of low risk patients with papillary thyroid cancer: role of neck ultrasonography in detecting lymph node metastases. , 2004, The Journal of clinical endocrinology and metabolism.
[66] P. Arveux,et al. Predictive value for disease progression of serum thyroglobulin levels measured in the postoperative period and after (131)I ablation therapy in patients with differentiated thyroid cancer. , 2004, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[67] A. Miyauchi,et al. Preoperative Ultrasonographic Examination for Lymph Node Metastasis: Usefulness when Designing Lymph Node Dissection for Papillary Microcarcinoma of the Thyroid , 2004, World Journal of Surgery.
[68] C. Bal,et al. Radioiodine dose for remnant ablation in differentiated thyroid carcinoma: a randomized clinical trial in 509 patients. , 2004, The Journal of clinical endocrinology and metabolism.
[69] A. Buescu,et al. Retinoic acid in patients with radioiodine non-responsive thyroid carcinoma , 2004, Journal of endocrinological investigation.
[70] T. Montesano,et al. Lung metastases from differentiated thyroid carcinoma. A 40 years' experience. , 2004, The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of....
[71] L. Ward,et al. [Thyroid cancer: prognostic factors and treatment]. , 2004, Arquivos brasileiros de endocrinologia e metabologia.
[72] G. Medeiros-Neto,et al. [Ultrasonographic evaluation of thyroid nodules: comparison with cytologic and histologic diagnosis]. , 2004, Arquivos brasileiros de endocrinologia e metabologia.
[73] J. H. Romaldini,et al. [Subclinical thyroid disease: subclinical hypothyroidism and hyperthyroidism]. , 2004, Arquivos brasileiros de endocrinologia e metabologia.
[74] J. Franklyn,et al. Subclinical thyroid disease: scientific review and guidelines for diagnosis and management. , 2004, JAMA.
[75] Bruno D Fornage,et al. Role of preoperative ultrasonography in the surgical management of patients with thyroid cancer. , 2003, Surgery.
[76] P. Hall,et al. Second primary malignancies in thyroid cancer patients , 2003, British Journal of Cancer.
[77] Seung-Yong Jeong,et al. Prevalence and risk of cancer of focal thyroid incidentaloma identified by 18F-fluorodeoxyglucose positron emission tomography for metastasis evaluation and cancer screening in healthy subjects. , 2003, The Journal of clinical endocrinology and metabolism.
[78] J. Shah,et al. Prognostic indicators of outcomes in patients with distant metastases from differentiated thyroid carcinoma. , 2003, Journal of the American College of Surgeons.
[79] A. Pinchera,et al. Recombinant human thyrotropin-stimulated serum thyroglobulin combined with neck ultrasonography has the highest sensitivity in monitoring differentiated thyroid carcinoma. , 2003, The Journal of clinical endocrinology and metabolism.
[80] J. Buckner,et al. Management of brain metastases from thyroid carcinoma , 2003, Cancer.
[81] J. Chan,et al. Papillary microcarcinoma of the thyroid—Prognostic significance of lymph node metastasis and multifocality , 2003, Cancer.
[82] F. Biancari,et al. Predictors of outcome for patients with differentiated and aggressive thyroid carcinoma. , 2003, The European journal of surgery. Supplement. : = Acta chirurgica. Supplement.
[83] J. Romijn,et al. Outcome of palliative embolization of bone metastases in differentiated thyroid carcinoma. , 2003, The Journal of clinical endocrinology and metabolism.
[84] J. Romijn,et al. Effects of low‐iodide diet on postsurgical radioiodide ablation therapy in patients with differentiated thyroid carcinoma , 2003, Clinical endocrinology.
[85] Stephanie L. Lee,et al. A consensus report of the role of serum thyroglobulin as a monitoring method for low-risk patients with papillary thyroid carcinoma. , 2003, The Journal of clinical endocrinology and metabolism.
[86] Koichi Ito,et al. Lymph Node Metastasis From 259 Papillary Thyroid Microcarcinomas: Frequency, Pattern of Occurrence and Recurrence, and Optimal Strategy for Neck Dissection , 2003, Annals of surgery.
[87] S. Mandel,et al. Radioactive iodine and the salivary glands. , 2003, Thyroid : official journal of the American Thyroid Association.
[88] E. Baudin,et al. Positive predictive value of serum thyroglobulin levels, measured during the first year of follow-up after thyroid hormone withdrawal, in thyroid cancer patients. , 2003, The Journal of clinical endocrinology and metabolism.
[89] L. Hegedüs,et al. A prospective study of thyroid function, morphology and autoimmunity in young patients with type 1 diabetes. , 2003, European journal of endocrinology.
[90] C. Ginter,et al. The sodium/iodide Symporter (NIS): characterization, regulation, and medical significance. , 2003, Endocrine reviews.
[91] S. Libutti,et al. Role of metastasectomy in the management of thyroid carcinoma: The NIH experience , 2003, Journal of surgical oncology.
[92] P. Caron,et al. Effects of thyroid-stimulating hormone suppression with levothyroxine in reducing the volume of solitary thyroid nodules and improving extranodular nonpalpable changes: a randomized, double-blind, placebo-controlled trial by the French Thyroid Research Group. , 2002, The Journal of clinical endocrinology and metabolism.
[93] P. Caraballo,et al. Effectiveness of thyroid hormone suppressive therapy in benign solitary thyroid nodules: a meta-analysis. , 2002, The Journal of clinical endocrinology and metabolism.
[94] A. Oberg,et al. Papillary Thyroid Carcinoma Managed at the Mayo Clinic during Six Decades (1940–1999): Temporal Trends in Initial Therapy and Long-term Outcome in 2444 Consecutively Treated Patients , 2002, World Journal of Surgery.
[95] D. Lee,et al. Clinical significance of elevated level of serum antithyroglobulin antibody in patients with differentiated thyroid cancer after thyroid ablation , 2002, Clinical endocrinology.
[96] Q. Duh,et al. Complications of Neck Dissection for Thyroid Cancer , 2002, World Journal of Surgery.
[97] C. Harmer,et al. Testicular dose and fertility in men following I131 therapy for thyroid cancer , 2002, Clinical endocrinology.
[98] C. Compton,et al. TNM residual tumor classification revisited , 2002, Cancer.
[99] Anna Crescenzi,et al. Risk of malignancy in nonpalpable thyroid nodules: predictive value of ultrasound and color-Doppler features. , 2002, The Journal of clinical endocrinology and metabolism.
[100] A. Pinchera,et al. Diagnostic 131-iodine whole-body scan may be avoided in thyroid cancer patients who have undetectable stimulated serum Tg levels after initial treatment. , 2002, The Journal of clinical endocrinology and metabolism.
[101] M. Sonenberg. Low-iodine diet in the treatment of differentiated thyroid cancer with radioactive iodine , 2002, Endocrine.
[102] G. Zettinig,et al. Long‐term follow‐up of patients with bone metastases from differentiated thyroid carcinoma – surgery or conventional therapy? , 2002, Clinical endocrinology.
[103] C. Harmer,et al. Prognosis for fertility and ovarian function after treatment with radioiodine for thyroid cancer , 2002, Postgraduate medical journal.
[104] M. Knobel,et al. Prognostic value of serial serum thyroglobulin determinations after total thyroidectomy for differentiated thyroid cancer , 2002, Journal of endocrinological investigation.
[105] G. Csako,et al. Effects of thyroid hormone suppression therapy on adverse clinical outcomes in thyroid cancer , 2002, Annals of medicine.
[106] S. Larson,et al. Resistance of [18f]-fluorodeoxyglucose-avid metastatic thyroid cancer lesions to treatment with high-dose radioactive iodine. , 2001, Thyroid : official journal of the American Thyroid Association.
[107] R. Vigneri,et al. Usefulness of recombinant human thyrotropin in the radiometabolic treatment of selected patients with thyroid cancer. , 2001, Thyroid : official journal of the American Thyroid Association.
[108] E. Koike,et al. Bronchoscopic diagnosis of thyroid cancer with laryngotracheal invasion. , 2001, Archives of surgery.
[109] P. Merlet,et al. Clinical impact of (18)F-FDG PET in thyroid carcinoma patients with elevated thyroglobulin levels and negative (131)I scanning results after therapy. , 2001, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[110] A. Pinchera,et al. Outcome of differentiated thyroid cancer with detectable serum Tg and negative diagnostic (131)I whole body scan: comparison of patients treated with high (131)I activities versus untreated patients. , 2001, The Journal of clinical endocrinology and metabolism.
[111] G. Braunstein,et al. Reevaluation of the impact of a stringent low-iodine diet on ablation rates in radioiodine treatment of thyroid carcinoma. , 2001, Thyroid : official journal of the American Thyroid Association.
[112] N. Sarlis. Metastatic thyroid cancer unresponsive to conventional therapies: novel management approaches through translational clinical research. , 2001, Current drug targets. Immune, endocrine and metabolic disorders.
[113] Amy Y. Chen,et al. The development of breast carcinoma in women with thyroid carcinoma , 2001, Cancer.
[114] S. Manolidis,et al. Thyroid Surgery: A Comparison of Outcomes between Experts and Surgeons in Training , 2001, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.
[115] A. Jennings. Evaluation of substernal goiters using computed tomography and MR imaging. , 2001, Endocrinology and metabolism clinics of North America.
[116] A. Abbruzzese,et al. Pamidronate improves the quality of life and induces clinical remission of bone metastases in patients with thyroid cancer , 2001, British Journal of Cancer.
[117] R. Solans,et al. Salivary and lacrimal gland dysfunction (sicca syndrome) after radioiodine therapy. , 2001, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[118] G. Hejblum,et al. Survival and therapeutic modalities in patients with bone metastases of differentiated thyroid carcinomas. , 2001, The Journal of clinical endocrinology and metabolism.
[119] R. Kloos,et al. Current Approaches to Primary Therapy for Papillary and Follicular Thyroid Cancer , 2001 .
[120] S. Mandel,et al. Usefulness of Ultrasonography in the Management of Nodular Thyroid Disease , 2000, Annals of Internal Medicine.
[121] Christopher Wong,et al. Thyroid Nodules: Rational Management , 2000, World Journal of Surgery.
[122] J. Pasieka. Hashimoto's Disease and Thyroid Lymphoma: Role of the Surgeon , 2000, World Journal of Surgery.
[123] J. Shah,et al. Initial results from a prospective cohort study of 5583 cases of thyroid carcinoma treated in the United States during 1996 , 2000, Cancer.
[124] A. King,et al. Staging papillary carcinoma of the thyroid: magnetic resonance imaging vs ultrasound of the neck. , 2000, Clinical radiology.
[125] B. Weintraub,et al. A comparison of recombinant human thyrotropin and thyroid hormone withdrawal for the detection of thyroid remnant or cancer. , 1999, The Journal of clinical endocrinology and metabolism.
[126] I. Fleming,et al. A National Cancer Data Base report on 53,856 cases of thyroid carcinoma treated in the U.S., 1985‐1995 , 1998, Cancer.
[127] A. Akdoğan,et al. Value of re-aspirations in benign nodular thyroid disease. , 1998, Thyroid : official journal of the American Thyroid Association.
[128] T. Ishigaki,et al. Preoperative staging of thyroid papillary carcinoma with ultrasonography. , 1998, European journal of radiology.
[129] J. Gross,et al. Suppressive therapy with levothyroxine for solitary thyroid nodules: a double-blind controlled clinical study and cumulative meta-analyses. , 1998, The Journal of clinical endocrinology and metabolism.
[130] P. Ladenson,et al. Outcome after Treatment of High-Risk Papillary and Non-Hurthle-Cell Follicular Thyroid Carcinoma , 1998, Annals of Internal Medicine.
[131] B Nygaard,et al. Observer variation in the clinical and laboratory evaluation of patients with thyroid dysfunction and goiter. , 1998, Thyroid : official journal of the American Thyroid Association.
[132] F. Rath,et al. Pattern of lymph node metastases in papillary thyroid carcinoma , 1998, The British journal of surgery.
[133] M. Schlumberger,et al. Papillary and follicular thyroid carcinoma. , 1998, The New England journal of medicine.
[134] H. Gharib,et al. Changing concepts in the diagnosis and management of thyroid nodules. , 1997, Endocrinology and metabolism clinics of North America.
[135] S. Sherman,et al. Prognosis and treatment of brain metastases in thyroid carcinoma. , 1997, The Journal of clinical endocrinology and metabolism.
[136] E. Mazzaferri,et al. Outcome of differentiated thyroid cancer diagnosed in pregnant women. , 1997, The Journal of clinical endocrinology and metabolism.
[137] E. Baudin,et al. 131I therapy for elevated thyroglobulin levels. , 1997, Thyroid : official journal of the American Thyroid Association.
[138] R. Hoover,et al. Solid cancers after bone marrow transplantation. , 1997, The New England journal of medicine.
[139] P. Caron,et al. Interest of routine measurement of serum calcitonin: study in a large series of thyroidectomized patients. The French Medullary Study Group. , 1997, The Journal of clinical endocrinology and metabolism.
[140] H. Gharib,et al. Thyroid Incidentalomas: Management Approaches to Nonpalpable Nodules Discovered Incidentally on Thyroid Imaging , 1997, Annals of Internal Medicine.
[141] B. Uzzan,et al. Effects on bone mass of long term treatment with thyroid hormones: a meta-analysis. , 1996, The Journal of clinical endocrinology and metabolism.
[142] P. Ladenson,et al. Treatment guidelines for patients with thyroid nodules and well-differentiated thyroid cancer. American Thyroid Association. , 1996, Archives of internal medicine.
[143] B. Nilsson,et al. Improved Survival of Patients with Papillary Thyroid Cancer after Surgical Microdissection , 1996, World Journal of Surgery.
[144] P. Ladenson,et al. Diagnostic accuracy of 131I scanning with recombinant human thyrotropin versus thyroid hormone withdrawal in a patient with metastatic thyroid carcinoma and hypopituitarism. , 1996, The Journal of clinical endocrinology and metabolism.
[145] M. Schlumberger,et al. Radioactive iodine treatment and external radiotherapy for lung and bone metastases from thyroid carcinoma. , 1996, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[146] A. Pinchera,et al. Exposure to radioactive iodine-131 for scintigraphy or therapy does not preclude pregnancy in thyroid cancer patients. , 1996, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[147] H. Burch,et al. Evaluation and management of the solid thyroid nodule. , 1995, Endocrinology and metabolism clinics of North America.
[148] K. Ain,et al. Iodine-131 therapy for thyroid cancer patients with elevated thyroglobulin and negative diagnostic scan. , 1995, The Journal of clinical endocrinology and metabolism.
[149] R. D'Agostino,et al. Low serum thyrotropin concentrations as a risk factor for atrial fibrillation in older persons. , 1994, The New England journal of medicine.
[150] S. Jhiang,et al. Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer. , 1994, The American journal of medicine.
[151] A. Pinchera,et al. Testicular function in patients with differentiated thyroid carcinoma treated with radioiodine. , 1994, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[152] S Chagnon,et al. The diagnostic value of fine-needle aspiration biopsy under ultrasonography in nonfunctional thyroid nodules: a prospective study comparing cytologic and histologic findings. , 1994, The American journal of medicine.
[153] D. Casara,et al. Clinical meaning of circulating antithyroglobulin antibodies in differentiated thyroid cancer: a prospective study. , 1992, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[154] A. Pinchera,et al. Detection of thyroglobulin in fine needle aspirates of nonthyroidal neck masses: a clue to the diagnosis of metastatic differentiated thyroid cancer. , 1992, The Journal of clinical endocrinology and metabolism.
[155] V S Hertzberg,et al. Radioiodine-131 therapy for well-differentiated thyroid cancer--a quantitative radiation dosimetric approach: outcome and validation in 85 patients. , 1992, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[156] Howard S. Smith,et al. Radioiodine-131 in the diagnosis and treatment of metastatic well differentiated thyroid cancer. , 1990, Endocrinology and metabolism clinics of North America.
[157] K. Robbins,et al. Metastatic papillary carcinoma of the thyroid: The significance of extranodal extension , 1989, Head & neck.
[158] J. Norton,et al. A Simplified Low Iodine Diet in I-131 Scanning and Therapy of Thyroid Cancer , 1988, Clinical nuclear medicine.
[159] A. Pinchera,et al. Serum thyroglobulin in thyroid carcinoma and other thyroid disorders , 1980, Journal of endocrinological investigation.
[160] D. Appleton,et al. THE SPECTRUM OF THYROID DISEASE IN A COMMUNITY: THE WHICKHAM SURVEY , 1977, Clinical endocrinology.
[161] G. Shambaugh,et al. Disparate thyroid imaging. Combined studies with sodium pertechnetate Tc 99m and radioactive iodine. , 1974, JAMA.
[162] C. Hill,et al. Chemotherapy of thyroid cancer with adriamycin. Experience with 30 patients. , 1974, The New England journal of medicine.
[163] C. Hill,et al. Chemotherapy of thyroid cancer. An evaluation of experience with 37 patients , 1972, Cancer.
[164] E. A. Gaston,et al. The significance of nontoxic thyroid nodules. Final report of a 15-year study of the incidence of thyroid malignancy. , 1968, Annals of internal medicine.
[165] T. P. Fox,et al. Monitoring thyroglobulin in a sensitive immunoassay has comparable sensitivity to recombinant human tsh-stimulated thyroglobulin in follow-up of thyroid cancer patients. , 2007, The Journal of clinical endocrinology and metabolism.
[166] Matthew J Hayat,et al. Cancer statistics, trends, and multiple primary cancer analyses from the Surveillance, Epidemiology, and End Results (SEER) Program. , 2007, The oncologist.
[167] J. Franklyn,et al. 131I activity for remnant ablation in patients with differentiated thyroid cancer: A systematic review. , 2007, The Journal of clinical endocrinology and metabolism.
[168] L. Ward,et al. Prevalence of papillary microcarcinoma of the thyroid in Brazilian autopsy and surgical series , 2006, Endocrine pathology.
[169] E. Pearce,et al. Clinical and histological characteristics of papillary thyroid microcarcinoma: results of a retrospective study in 243 patients. , 2006, The Journal of clinical endocrinology and metabolism.
[170] E. Baudin,et al. Long-term outcome of 444 patients with distant metastases from papillary and follicular thyroid carcinoma: benefits and limits of radioiodine therapy. , 2006, The Journal of clinical endocrinology and metabolism.
[171] A. Di Giorgio,et al. Comparative evaluation of recombinant human thyrotropin-stimulated thyroglobulin levels, 131I whole-body scintigraphy, and neck ultrasonography in the follow-up of patients with papillary thyroid microcarcinoma who have not undergone radioiodine therapy. , 2006, The Journal of clinical endocrinology and metabolism.
[172] R. Kloos,et al. A single recombinant human thyrotropin-stimulated serum thyroglobulin measurement predicts differentiated thyroid carcinoma metastases three to five years later. , 2005, The Journal of clinical endocrinology and metabolism.
[173] R. Wahl,et al. Recombinant human thyrotropin stimulation of fluoro-D-glucose positron emission tomography uptake in well-differentiated thyroid carcinoma. , 2004, The Journal of clinical endocrinology and metabolism.
[174] A. Pinchera,et al. Impact of routine measurement of serum calcitonin on the diagnosis and outcome of medullary thyroid cancer: experience in 10,864 patients with nodular thyroid disorders. , 2004, The Journal of clinical endocrinology and metabolism.
[175] T. Furlanetto,et al. Ultrasonography: Is it useful in the diagnosis of cancer in thyroid nodules? , 2002, Journal of endocrinological investigation.
[176] R. Hinze,et al. Pattern of Nodal Metastasis for Primary and Reoperative Thyroid Cancer , 2002, World journal of surgery.
[177] A. Pinchera,et al. Radioiodine treatment of metastatic differentiated thyroid cancer in patients on L-thyroxine, using recombinant human TSH. , 2001, European journal of endocrinology.
[178] E. Baudin,et al. Is diagnostic iodine-131 scanning useful after total thyroid ablation for differentiated thyroid cancer? , 2000, The Journal of clinical endocrinology and metabolism.
[179] B. Haugen. Management of the patient with progressive radioiodine non-responsive disease. , 1999, Seminars in surgical oncology.
[180] A. Pontecorvi,et al. Diagnostic accuracy of conventional versus sonography-guided fine-needle aspiration biopsy of thyroid nodules. , 1998, Thyroid : official journal of the American Thyroid Association.
[181] P. Ladenson,et al. Thyrotropin suppression and disease progression in patients with differentiated thyroid cancer: results from the National Thyroid Cancer Treatment Cooperative Registry. , 1998, Thyroid : official journal of the American Thyroid Association.
[182] I. Hay,et al. Thyroid cancer nodal metastases: biologic significance and therapeutic considerations. , 1996, Surgical oncology clinics of North America.
[183] E. Bergstralh,et al. Papillary thyroid microcarcinoma : a study of 535 cases observed in a 50-year period: Discussion , 1992 .
[184] L. Davies,et al. Increasing incidence of thyroid cancer in the United States, 1973-2002. , 2006, JAMA.